SMOKING, HEALTHCARE COST AND LOSS OF PRODUCTIVITY IN INDONESIA Created by: dr. DIAH EVASARI HUSNULKHOTIMAH, MPH

Similar documents
Tobacco Health Cost in Egypt

Tobacco Treatment Measures KATHY WONDERLY RN, MSED, CPHQ CONSULTANT DEVELOPED: JANUARY 2018

Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN)

The Social Cost of Smoking in Singapore

THE ECONOMICS OF TOBACCO AND TOBACCO TAXATION IN BANGLADESH

Health and Economic Burden of Major Cancers Due to Smoking in Korea

TOBACCO TREATMENT INPATIENT QUALITY MEASURES. Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: December 2015

August 2009 Ceri J. Phillips and Andrew Bloodworth

Performance Measure Name: TOB-3 Tobacco Use Treatment Provided or Offered at Discharge TOB-3a Tobacco Use Treatment at Discharge

National Burden of Cancers Attributable to Secondhand Smoking in Indonesia

The Cost of Alcohol and Drug Abuse in Maine, 2010

Trends in Pneumonia and Influenza Morbidity and Mortality

T obacco use is one of the most important contributors to

Cancer Disparities in Arkansas: An Uneven Distribution. Prepared by: Martha M. Phillips, PhD, MPH, MBA. For the Arkansas Cancer Coalition

GATS Highlights. GATS Objectives. GATS Methodology

ISBN: Centre for Tobacco Control in Africa (CTCA), 2017

Cigarette Consumption in China ( ) Cigarette Consumption in Poland ( )

Availability, Affordability, and Prices of Smoking Cessation Drugs in 9 Countries: Preliminary Findings

Appendix. Background Information: New Zealand s Tobacco Control Programme. Report from the Ministry of Health

COSTS OF HEALTH SERVICES UTILIZATION OF PEOPLE WITH FETAL ALCOHOL SPECTRUM DISORDER BY SEX AND AGE GROUP IN ALBERTA, CANADA

A conservative estimate of annual costs for lead poisoning, asthma, cancer and selected neurodevelopmental disabilities A report prepared by

Tuscarawas County Health Department

Cost of Diabetes. Laura Keller Director State Advocacy AK CO HI ID MT ND OR SD WA WY

Memorias Convención Internacional de Salud Pública. Cuba Salud La Habana 3-7 de diciembre de 2012 ISBN

The impact of respiratory disease in New Zealand: 2018 update

Tobacco control: Best practices. Tara Singh Bam The Union Asia Pacific, Singapore

The Economics of Tobacco and Tobacco Taxation in Bangladesh: Abul Barkat et.al

Report: The Business Case for Coverage of Tobacco Cessation

Healthcare and productivity savings from increased intake of grain fibre in New Zealand.

Tobacco OR Health. Tara Singh Bam, PhD, MPH

The Healthy Indiana Plan

Technical Appendix I26,I27.1,I28,I43-45,I47.0- I47.1,I47.9,I48,I ,I51.0- I51.4,I52,I77-I84,I86-I97,I98.1-I98.8,I99

TOBACCO CONTROL ECONOMICS TOBACCO FREE INITIATIVE PREVENTION OF NONCOMMUNICABLE DISEASES

RESEARCH ARTICLE. Effects of Smoking on Cost of Hospitalization and Length of Stay among Patients with Lung Cancer in Iran: a Hospital- Based Study

RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS

The Costs of Tobacco Use in Canada, 2012.

Chapter 1. Introduction. Teh-wei Hu

S05-1 Social-economic impact of diabetes in New Zealand

Tobacco-related Illnesses

Management of Non-communicable Diseases - Prevention Vs. Intervention

The Economic Burden of Hypercholesterolaemia

How to evaluate the economic impact of interventions I: introduction and costing analyses

2019 March. Tobacco Facts: Consumption, Mortality, and Morbidity. Center for Urban Population Health University of Wisconsin-Milwaukee

GATS Philippines Global Adult Tobacco Survey: Executive Summary 2015

Performance Measure Name: Tobacco Use: Assessing Status after Discharge

SMOKELESS TOBACCO IN THE CONTEXT OF TOBACCO HARM REDUCTION

Diabetes mellitus is a disorder caused by insufficient or non

Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use

State Tobacco Control Programs

Never has there been a more

Health systems challenges for tobacco dependence treatment in LMICs: Smokeless tobacco and Bidi

7/29/2010. Sharon Moffatt RN BSN MSN Chief of Health Promotion Association of State and Territorial Health July 25, 2010.

Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women

Costing the burden of ill health related to physical inactivity for Scotland

Estimating the Cost of Pediatric Asthma Attributable to the Environment Michigan, 2013

Fumo, riduzione del danno e rischio oncologico

- Description, Objectives, Operational Framework

Fast Facts. Morbidity and Mortality (Related to Tobacco Use)

John T. Mather Memorial Hospital and St. Charles Hospital Community Health Needs Assessment: Cancer Executive Summary

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

State Tobacco Control Spending and Youth Smoking

Estimating the economic value of reducing smoking rates in Canada to 18% and the cost of failing to achieve the 12% goal.

Save Lives and Save Money

Investing in Best Practices for Asthma: A Business Case

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both

Smoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014

Nicotine replacement therapy to improve quit rates

Local Laws to Raise the Minimum Legal Sale Age for all Tobacco Products 21 Years of Age in the North Country Frequently Asked Questions

TOBACCO CONTROL & THE SUSTAINABLE DEVELOPMENT GOALS

10/27/15. Presenter Disclosures. Objec4ve. Winston Liao. 143 rd Annual APHA. Winston Liao. No relationships to disclose

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

A COMPREHENSIVE REPORT ISSUED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS IN PARTNERSHIP WITH:

LAO PEOPLE'S DEMOCRATIC REPUBLIC

TOBACCO AND SMOKING PROGRESS AND CHALLENGE IN DISEASE PREVENTION DAVID DOBBINS COO

National Center for Chronic Disease Prevention and Health Promotion. Overweight and Obesity Frequently Asked Questions (FAQs)

Health Care in Appalachia. Foundations of Modern Health Care, Lecture 12 Anya K. Cope, DO

The cost of the double burden of malnutrition. April Economic Commission for Latin America and the Caribbean

WESTERN PACIFIC REGION HEALTH DATABANK, 2011 Revision. Total Total. Number of new cases. Total

Annual Tobacco Report 2000

PERINATAL TOBACCO USE

Global Adult Tobacco Survey TURKEY. Dr. Peyman ALTAN MoH Tobacco Control Dep. Ankara November 2018

OTPC executive committee is comprised of volunteers representing various community sectors within Oklahoma. The Oklahoma Turning Point Council

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

Where We Are: State of Tobacco Control and Prevention

Submission by the Federation of European Cancer Societies to the Public Hearings on the WHO Framework Convention on Tobacco Control

Oregon Asthma Surveillance Summary Report August 2006

Recommendation 1: Promote Kidney Disease Prevention Research

Project Report. Economic model of adult smoking related costs and consequences for England. October 2010 Revised: April 2011

The Cost of Overweight and Obesity on the Island of Ireland

New Jersey s Comprehensive Tobacco Control Program: Importance of Sustained Funding

ECONOMIC AND FINANCIAL ANALYSIS

Tobacco Use in Adolescents

China s Health Reform, Chronic Disease Burden and the Elderly

WESTERN PACIFIC REGION HEALTH DATABANK, 2011 Revision. Total

Guideline scope Smoking cessation interventions and services

Smoking-attributable cancer mortality in California, 1979e2005

ADA 2007 Cost of Diabetes in the United States -

EXECUTIVE SUMMARY. 1 P age

Healthcare expenditure and productivity cost savings resulting from increased intake of grain fibre in Australia.

Socioeconomic Factors

Transcription:

SMOKING, HEALTHCARE COST AND LOSS OF PRODUCTIVITY IN INDONESIA 2010 Created by: dr. DIAH EVASARI HUSNULKHOTIMAH, MPH

1. Introduction 1.1 Background of the Study 1.2 Research Question 1.3 Significance of the Study 1.4 Research Objective 1.5 Research Hypothesis 1.6 Scope of the Study

1.1 Background of the Study According to WHO s projection, in 2020 tobaccorelated illnesses will become the largest single health problem, causing an estimated 8.4 million deaths globally per year. Indonesian Global Adult Tobacco Survey report of 2011 showed that 67.4% of men and 4.5% of women comprising 36.1% of the population (61.4 million) used tobacco in smoked or smokeless form. Indonesians consume the fifth largest amount of tobacco globally in 2002.

Indonesian National Survey in 2009 showed that 62% of men and 1% 3% of women are smokers. Studies on smoking cost estimate in Indonesia is limited Indonesia was being the only Asian country out of 41 countries attending the Asia Pacific Conference on Tobacco or Health (APACT) not to have signed the World Health Organization s Framework Convention on Tobacco Control (FCTC)

1.2 Research Question How much were healthcare costs and loss of productivity due to smoking in Indonesia in 2010? 1.3 Significance of the Study Empower people and the government on tobacco control advocacy 1.4 Research Objective To estimate healthcare cost and loss of productivity due to smoking in Indonesia 2010

1.5 Research Hypothesis Smoking can cause smoking-attributable expenditure related to smoking attributable diseases and deaths. 1.6 Scope of the Study Health care cost (direct cost) and productivity losses (indirect cost) duet to smoking are calculated. Healthcare cost includes inpatient services, outpatient services, and prescription drugs. Indirect cost includes productivity losses due to illness and premature death.

3. RESEARCH METHODOLOGY Prevalence-based approach Private perspective 3.1 Source of Data 3.2 Direct Cost 3.3 Indirect Cost 3.4 Type of Diseases 3.5 Data Analyses

3.1 Source of Data 2007 BHR (Baseline Health Research 2010 BHR 2010 NSS (National Socioeconomic Survey) Population Census of 2010 Report of Annual Gross National Income of 2010 Report of Labor Participation Rate

3.2 Direct Cost 3.2.1 ESTIMATING HEALTHCARE EXPENDITURE OF 2010 Healthcare expenditure are determined according to data of 2010 BHR (Baseline Health Research) and 2010 NSS (National Socioeconomic Survey). The average of per person health expenditure are calculated according to age groups (20-34, 35-64 and >= 65) for the 2010 BHR and the 2010 NSS, respectively. An average of the results gained from the two database was calculated and applied to population census data of 2010 according to the age groups.

3.2.2 ESTIMATING THE SAF (SMOKING ATTRIBUTABLE FRACTION) RR c = r c /rn and RR f = r f /r n where r c = rate of illness or death for current smokers r f = rate of illness or death for former smokers r n = rate of illness or death for never smokers RR c = relative risk for current smokers relative to never smokers RR f = relative risk for former smokers relative to never smokers

SAF = [(p n + p c (RR c ) + p f (RR f )] 1 [(p n + p c (RR c ) + p f (RR f )] where p n = percentage of never smokers in the region p c p f Rr c Rr f = percentage of current smokers in the region = percentage of former smokers in the region = relative risk for current smokers relative to never smokers = relative risk for former smokers relative to never smokers

3.2.3 ESTIMATING SMOKING ATTRIBUTABLE EXPENDITURES Smoking-attributable expenditures are estimated for each disease, for males and females, and for each age groups. Once the SAFs are obtained they are multiplied by the corresponding health care expenditure.

3.3 Indirect Cost 3.3.1 LOST PRODUCTIVITY DUE TO ILLNESS 3.1.1 Estimating work loss days ork loss days in this paper is defined as the length of stay in althcare services. First, the average annual length of stay for inpatient rvices per adult aged 20 and older in Indonesia were estimated by ales and females (separately) and by 20-34, 35-64 and age groups, ing the 2010 NSS data. Second, these average days were multiplied Indonesian population based on 2010 census to derive the total days ent in inpatient care in 2010.

3.3.1.2 Estimating SAF The same with direct cost 3.3.1.3 Estimating Smoking Attributable Work Loss Days The SAF for days lost is applied to the total number of days lost to obtain smoking-attributable days of lost productivity. Work loss days are divided by 365 days (1 year) and are valued using Indonesian Gross National Income (GNI) of 2010.

3.3.2 LOST OF PRODUCTIVITY DUE TO PREMATURE DEATHS 3.3.2.1 DEATHS ATTRIBUTED TO SMOKING The SAF for each age group, gender, and disease is applied to the corresponding number of deaths to determine the number of smoking attributable deaths. The SAF is determined according to the formula presented previously using the relative risk of death published by the Surgeon General (US DHHS 1989) and the 2010 smoking prevalence in Indonesia. Deaths for each smoking-related diagnosis was obtained from the 2007 BHR mortality data.

3.3.2.2 YEARS OF POTENTIAL LIFE LOST (YPLL) YPLL is the number of years people would have, had they not died of smoking-related disease. The number of years lost is estimated as the average number of years of life expectancy remaining at the age of death. Thus, smokingrelated deaths (by gender and 3 age groups) are multiplied by the number of years of life expectancy remaining. The data of life expectancy was obtained from CIA Worldfact book of 2010 Thus: Smoking-attributable YPLL = deaths x SAF x YPLL

3.3.2.3 ESTIMATION OF THE VALUE OF SMOKING- ATTRIBUTABLE LOST PRODUCTIVITY FROM PREMATURE DEATH The cost to society of smoking-attributable mortality is calculated as the product of the number of deaths and the present value of lifetime earnings (PVLE) for each person. This calculation takes into account labor market earnings by using GNI as proxy and the probability that a person will be in the labor market for each age group and gender. GNI of 2010 is obtained by projecting the GNI of the previous 10 years (since 2000)

Present Value of Life Earnings The PVLE is calculated as: 99 PVLE = Σ Py,g (n) [Yg(n) Eg(n) ] * (1+p) n-y / (1+r)n-y n=y where PVLE is the present discounted value of lifetime earnings per person Py,s(n) is the probability that a person of gender g will survive to age n y is the age of the person at death

g is the gender of the individual n is the age of the person Yg(n) is the mean annual earnings of an employed person of gender g and age n. In this paper, due to lack of data GNI is used as a proxy for all gender and age groups. Eg(n) is the proportion of the population of gender g and age n that are employed in the labor market p is the rate of increase of labor productivity r is the real discount rate

3.4 Type of Diseases Heart Disease and Neoplasm

3.5 Data Analysis All of the calculation and descriptive analysis done in this paper use 16 th Version of SPSS and Microsof Excel of Windows7.

4. RESULT AND DISCUSSION 4.1 Prevalence of Smoking In Indonesia 2010 4.2 Smoking Attributable Fraction 4.3 The Direct Cost of Smoking in Indonesia 2010 4.4 The Morbidity Cost /Loss of Productivity due to Illness in Indonesia 2010 4.5 The Smoking-Attributable Deaths Estimate in Indonesia 2010 4.6 The Mortality Cost/Loss of Productivity due to Premature Deaths in Indonesia 2010 4.7 The Cost of Smoking in Indonesia 2010

4.1 Prevalence of Smoking In Indonesia 2010 Table 6. Smoking Prevalence of People Aged 15 Years and Older by Gender, Indonesia (in %)

4.2 Smoking Attributable Fraction Table 10. Smoking Attributable Fraction (SAF) of the Morbidity, Indonesia, 2010

Table 11. Smoking Attributable Fraction (SAF) of the Mortality, Indonesia, 2010 Total >= 65 35-64 20-34 Female >= 65 35-64 20-34 Pulmonary Heart Disease Lip, oral cavity,pharynx Trachea, lung,bronchus Kidney, and other urinary Cervix, uterus Digestive tract(intestine, liver) Blood Male 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1

4.3 The Direct Cost of Smoking in Indonesia 2010 Table 12. Direct Cost of Smoking by Gender, Age and Type of Expenditure, Indonesia, 2010 (in Billion Rp.) >= 65 35-64 20-34 Female, Total 268.02 823.62 306.77 1398.41 Inpatient Services Outpatient Services Prescriptions Total >= 65 35-64 20-34 Male, Total Total 834.24 2858.05 3310.38 7002.67 8401.08 0 1000 2000 3000 4000 5000 6000 7000 8000 9000

4.4 The Morbidity Cost /Loss of Productivity due to Illness in Indonesia 2010 Table 14.Days Lost and Productivity Losses Attributed to Smoking by Gender and Cause of Hospitalization, Indonesi 2010 (in Billion Rp.) 30 25 22.13 25.85 20 15 10 13.19 16.13 8.94 9.73 Female, Total Male, Total Total 5 0 2.93 3.73 0.79 Heart Disease Neoplasm Total

4.5 The Smoking-Attributable Deaths Estimate in Indonesia 2010

Years of Potential Life Lost per Death (in years)

4.6 The Mortality Cost/Loss of Productivity due to Premature Deaths in Indonesia 2010 Table 21. Deaths, Years of Potential Life Lost, and Productivity Losses Attributed to Smoking, Indonesia, 2010 (In Billion Rp.)

4.7 The Cost of Smoking in Indonesia 2010

Table 24. Cost of Smoking by Type of Cost and Gender, Indonesia, 2010 (in Billion Rp.)

5. CONCLUSION AND RECOMMENDATION 5.1. Conclusion It was estimated that the total costs of smoking in Indonesia in 2010 were Rp. 61.4 trillion(usd 7.9 billion) or 2.8 % of GDP. It consists of 13.7% direct costs and 86.3% indirect costs. The costs of smoking incurred by males is very much higher than that of females.

5.2 Recommendation Further research is needed, preferably using a cohort method and targeting specific groups such as women, adolescent and other groups of interest to policy makers. The author intends that this paper could be useful to convince the local government to establish policy towards tobacco control on the basis of national settings.

THANK YOU Pamulang, March 30 th 2015